Skip to content
Log in Get started
Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor
Financial data updated nightly

Suzhou Zelgen Biopharmaceuticals Co Ltd

688266.SS ✓ COMPLIANTFree checks used up today ☆ Track — members
Shanghai Stock Exchange · Healthcare · Pharmaceuticals ·
China Mid Cap Analyst: STRONG BUY
Last Close
$13.66
▲ +9.05%
Market Cap $3.62B · Vol 5.25M
Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans
Key Metrics
P/E Ratio
42.42
FWD: 55.22
Market Cap
$3.62B
Mid Cap
Div Yield
N/A
Annual dividend
EPS Growth
+416.27%
YoY
RSI (14)
46.20
Momentum
Beta
0.97
vs Market
52W High
$23.98
42.10% below
52W Low
$11.25
25.43% above
Volume
5.25M
Avg 3.73M
P/B
22.54
Price-to-book
ROE
-13.67%
Return on equity
Free Float
71.80%
Public shares
Shariah Compliance8 STANDARDS
✓ Yes, Suzhou Zelgen Biopharmaceuticals Co Ltd (688266.SS) stock is Shariah compliant
You’ve used your 10 free compliance checks today

Sign up and choose a plan to keep checking — unlimited checks, all 8 standards, purification and zakat per share.

Choose a plan
  • AAOIFI—
  • Dow Jones Islamic (DJIM)—
  • FTSE Shariah—
  • MSCI Islamic—
  • S&P Shariah—
  • Al Rajhi—
  • Alinma—
  • Albilad—
Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does 688266.SS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns
5D
+1.28%
1M
-17.15%
3M
-15.05%
6M
-12.37%
YTD
-1.68%
1Y
-12.09%
3Y
+121.23%
5Y
+45.52%
Financials & Valuation
TTM · Annual
Total Revenue$115.90M
Net Income$-23,612,820.00
Revenue Growth (YoY)+220.88%
Gross Margin90.01%
Operating Margin-24.54%
Net Profit Margin-20.37%
ROE-13.67%
ROA · ROIC-5.65% · N/A
P/E Ratio42.42
Forward P/E (FY1)55.22
PEG RatioN/A
P/S30.28
P/B22.54
P/FCFN/A
EPS Growth+416.27%
Outstanding Shares264.71M
Technical Indicators
50-Day SMA$16.13
200-Day SMA$15.53
RSI (14)46.20
Beta0.97
52-Week High$23.98
52-Week Low$11.25
Volume Today5.25M
Avg Daily Volume (30D)3.73M
Relative Volume1.41x
Volatility (10D)83.83
Volatility (30D)64.12
Free Float71.80%
AAOIFI Certified Shariah Advisor and Auditor certificate